Pharmaceutical Raw Materials Trilostane For Breast Cancer Treatment
Superioridad
Zhongshan Latterson Biotechnology Co., Limitado., es una empresa farmacéutica integral, que se especializó en tecnología biofarmacéutica sobre 7 años. La empresa está ubicada en la ciudad de Zhongshan, Provincia de Guangdong , porcelana.
Nuestra fábrica cubre un área de 33500 metros cuadrados, con un ambiente limpio y un diseño agradable. Hay varios talleres grandes o medianos y un centro de investigación y control de calidad con equipos avanzados.. En el presente, Nuestros principales productos son la serie de esteroides anabólicos., Serie de péptidos, Serie de anestésicos locales. Nuestros productos alcanzan el estándar avanzado del mercado nacional., muchos de los cuales alcanzan el estándar internacional, los certificados contienen: COMESTIBLE SEGÚN LA LEY JUDÍA , YO ASI 9001:2008 , GMP , SGS.
Detalle rápido:
trilostano
No CAS.: 13647-35-3
Pureza: 98.5%min
MF: C20H27NO3
EINECS No.: 237-133-0
Apariencia: White to off-white power
Type: Antineoplastic Agents
Grade Standard: Grado de Medicina
Embalaje: As customers requirments
Uso: Anti-tumor drugs and immunosuppressants
Descripción
trilostano, that is 4α, 5α-epoxy-2-cyano-3,17β-diol, can reversibly inhibit 3β-hydroxy steroid dehydrogenase and △5, 4-isomerase in the adrenal cortex to block the biosynthesis of mineralocorticoid and glucocorticoid. En 1980, it was approved for the treatment of hyperaldosteronism and cortisol excess disease in the United Kingdom. En 1985, it was approved for the treatment of Cushing’s syndrome in the United States, which is adrenal cortex hyperactivity disorder. In view of the older animals, especially older dogs are susceptible to Cushing’s syndrome. Trilostane can relieve the disease symptoms of more than 90% of dogs, and improve their quality of life. So the drug has also been granted for the treatment of animals in the United Kingdom. Trilostane itself has no hormonal activity. Its side effects is less, and its safety and tolerability are also particularly good.
Solicitud
1) trilostano,The anti estrogen steroids drug Trilostane was previously available in the United Kingdom for use in humans under the brand name Modrenal for the treatment of Cushing’s disease and for breast cancer. It was approved in the United States in 2008 for the treatment of Cushing’s disease (hyperadrenocorticism) in dogs under the brand name Vetoryl.
2) It was available by prescription in the UK under the Vetoryl brand name for some time before it was approved in the US. The drug is also used to treat the skin disorder Alopecia X in dogs. It is also the first drug approved to treat both pituitary- and adrenal-dependent Cushing’s in dogs. This prescription drug works by stopping the production of cortisol in the adrenal glands.
3) trilostano,The anti estrogen steroids drug Vetoryl is used to treat Cushing’s syndrome (also known as Cushings disease or hyperadrenocorticism). This is a hormone problem associated with abnormally high levels of cortisone in the blood stream of affected dogs. The main symptoms caused are excessive thirst and hunger. It also affects the dog’s appearance and reduces its quality of life. Dogs may show hair loss, weight gain, lethargy, loss of bladder control and a bloated stomach.
4) trilostano,Cushing’s disease is a condition that will be present in the dog’s system for the rest of its life and will need to be treated continually. Vetoryl tackles this problem in the pituitary and adrenal glands. Cortisol levels are reduced which leads to a reduction in symptoms and Vetoryl can make a difference in just three months.
5) trilostano,The capsules are available in four strengths depending on the size of the dog and should only be prescribed by a vet. There are a number of contra-indications which should be taken into consideration prior to treatment. Dogs that are pregnant or who have problems with the liver or kidneys should not take this medication.
Indications
Trilostane can inhibit 3β-dehydrogenase in the synthesis of corticosteroids, and decrease the synthesis of cortisol and aldosterone. It also can be used in the treatment of Cushing’s syndrome (hypercortisolism) and primary aldosteronism. But the efficacy to treat Cushing’s syndrome (hypercortisolism) is not as metyrapone. This product also has a significant role in lowering blood testosterone levels, which may be related with that its synthesis is inhibited.
Preguntas más frecuentes
1.como empaquetar?
Contamos con un equipo profesional para el paquete y el envío.. Manera especial de enviar 100 gramos a 100 kg de polvos a la vez a su país. Se puede organizar un envío rápido y discreto para pasar la aduana Garantizado.
2.como hacer la entrega?
Se admiten varias formas, como DHL, TNT, FEDEX, HKEMS, UPS, etc..
3.Cuanto tiempo se puede enviar el producto?
La mayoría de los polvos están en stock., muestras gratuitas están disponibles, el producto podría enviarse dentro de las 24 horas posteriores a la recepción del pago.
4.¿Hay alguna certificación??
Por supuesto que tenemos. Ya obtuvimos la certificación de ISO9001, puede confiar en nosotros,somos un fabricante confiable.
5.¿Qué hay de la tasa de pasar la aduana??
No es necesario preocuparse por el paso de aduanas. Nuestra empresa 100% pasar a Reino Unido, Noruega, Polonia, España, EE.UU, Canadá, Brasil; 98% pasar a alemania, Rusia, Australia, Nueva Zelanda.
Gerente de ventas